Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
January 03 2017 - 11:09AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 333-196065
Parnell Pharmaceuticals Holdings Ltd
(Exact name of registrant as specified in its charter)
Unit 4, Century Estate. 476 Gardeners Road. Alexandria 2015 NSW, Australia, 1800 665 882
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares, no par value
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
☒
|
|
|
|
Rule 12g-4(a)(2)
|
☐
|
|
|
|
Rule 12h-3(b)(1)(i)
|
☒
|
|
|
|
Rule 12h-3(b)(1)(ii)
|
☐
|
|
|
|
Rule 15d-6
|
☐
|
|
|
|
Rule 15d-22(b)
|
☐
|
|
|
Approximate number of holders of record as of the certification or notice date: 37
Pursuant to the requirements of the Securities Exchange Act of 1934, Parnell Pharmaceuticals Holdings Ltd has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
January 3, 2017
By
/s/ Brad McCarthy
Director and Chief Financial Officer
Date Name Title
Parnell Pharmaceuticals (CE) (USOTC:PARNF)
Historical Stock Chart
From Dec 2024 to Jan 2025
Parnell Pharmaceuticals (CE) (USOTC:PARNF)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Parnell Pharmaceuticals Holdings Ltd (CE) (OTCMarkets): 0 recent articles
More Parnell Pharmaceuticals Holdings Ltd News Articles